Click or Call
Phone

Click or Call

Get in touch to learn more about medical cannabis, share your thoughts & be in-the-know for exclusive offers, products, & events.

Monday to Friday
8 AM - 7 PM EST

Saturday & Sunday
9 AM - 5 PM EST

THC

ODRA

Hybrid with relaxed indica qualities

Odra® is produced from a hybrid Cannabis sativa and Cannabis indica plant and has a ratio of 60:1 THC: CBD. Patients describe Odra® as relaxed, euphoric, and mildly drowsy with an emphasis on its more focused effects on helping to alleviate migraine headaches. Odra® is a whole-plant product that contains concentrations of THC, CBD and a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.

Current medical literature supports the use of THC rich products for the treatment of all conditions approved for medical cannabis.

Read More

Cartridge 300 mg

CBD ContentApprox: 1%

THC ContentApprox: 30%

THC to CBD60:1

Dosing Units

Each vaporizer 300 mg cartridge contains 1 mg CBD/inhalation

Total Doses

Approx: 300 inhalations per cartridge (1ml)

$45.00

Shop Now

Key Benefits

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.

Instructions

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, patients reassess symptoms.

If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Warnings

Odra® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Odra®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

Cartridge 600 mg

CBD ContentApprox: 1%

THC ContentApprox: 60%

THC to CBD60:1

Dosing Units

Each vaporizer 600 mg cartridge contains 2 mg THC/inhalation

Total Doses

Approx: 300 inhalations per cartridge (1ml)

$90.00

Shop Now

Key Benefits

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.

Instructions

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, patients reassess symptoms.

If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Warnings

Odra® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Odra®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

Drops/Tincture

CBD ContentApprox: 1%

THC ContentApprox: 0.5mg/drop per 600 mg (1 ml)

THC to CBD60:1

Dosing Units

0.5mg/drop for sublingual drops

Total Doses

Approx: 1200 drops per 600 (30ml bottle)

$90

Shop Now

Key Benefits

Tinctures are absorbed sublingually, so essential cannabinoids are absorbed directly into the bloodstream. Effects are delayed through the absorption process but are prolonged. The application is very discreet, with no odor.

Instructions

Odra® oil is to be administered orally.  The starting dose is 2.5 mg/kg twice daily (5 mg/kg/day). Patients are recommended to initiate treatment on the evening of Day 1 with 2.5 mg/kg.  After 5-7 days, the dose can be gradually increased to 5 mg/kg twice a day (10 mg/kg/day).

Patients who are tolerating Odra® at 5 mg/kg twice daily and who may benefit from a dosage increase can be further titrated to a maximum recommended maintenance dosage of 10 mg/kg twice daily (20 mg/kg/day). This should be titrated over several weeks, as tolerated. Dosage should not be increased more frequently than every other day.

Warnings

Odra® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Odra®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

Capsules

CBD ContentApprox: 1%

THC ContentApprox: 30%

THC to CBD60:1

Dosing Units

10 mg per capsule

Total Doses

60 capsules per bottle

$115.00

Shop Now

Key Benefits

One the most discreet and convenient forms of consumption. The cannabinoids are processed and absorbed by the way of the liver, which means effects are more prolonged than most forms of cannabis ingestion. A diverse variety of options are available.

Instructions

Patients are recommended to initiate treatment on the evening of Day 1 with 1-2 sessions. Each session consists of taking 1 capsule and waiting for desired effects. After 1-2 hours, patients reassess symptoms.

If symptoms have improved or subsided, no additional dosing is needed and patients take the next dose that evening / the morning of Day 2. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Warnings

Odra® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Odra®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

    Find Dispensaries and PhysiciansMore locations coming soon.